Join the must-attend GamesBeat flagship event. This summer in Los Angeles, GamesBeat Summit brings together top leaders, CEOs, and dealmakers on May 18–19 to spark connections and close major deals. Don’t miss where gaming and business converge. To celebrate one year of going independent, enjoy a limited-time buy one, get one free offer—ending soon while supplies last. Secure your spot now before tickets sell out.
Colossal Biosciences made its name with an eye-catching mandate: It wants to “bring back” extinct species, using DNA extracted from what remains of the direwolf, the woolly mammoth, the thylacine and rebuilding it via their modern relatives. But during a tour of its headquarters in Dallas, I had the chance to ask a question that’s been on my mind since the news broke: Why?
I don’t just mean, “Why do this?” — I wanted to know what benefit Colossal’s research could have for us here in the modern world. Bringing back the wooly mammoth sounds scientifically edifying, but what would we do with it once it’s here?
This is exclusive GB MAX content. Members get full transcripts, in-depth analysis, and access to the conversations shaping the gaming industry — the stuff that doesn’t make the free feed.
Become a GB MAX Member starting at $299/year.
